PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

45,809 stories, page 667 of 764

Advanced search
🌍Researchdoi.orgTier 1 · Research record

A novel drug screening strategy based on non-invasive electrochemical detection of multiple tumor markers secreted by patient-derived microgel organoids

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Neurobiomarker-guided neuromodulation for youth with major depressive episodes: a double-blind randomized trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

From breadth to depth in clinical artificial intelligence evaluation

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Retraction Note: Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Efficacy and safety of hydrolyzed collagen supplementation on skin health outcomes: a systematic literature review of randomized controlled trials

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Aprepitant’s neuroprotective effects on methylphenidate-induced biochemical/mitochondrial dysfunction, neuroinflammation, and mood-related behavior alterations

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Mechanistic Insights into LGALS3-Mediated Osteoarthritis Progression: Activation of the cGAS-STING Pathway as a Key Driver of Senescence-Related Osteoarthritis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Multiparametric Characterization of Tough Clots Following Stroke Thrombectomy

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

“Protected time” for clinical investigators in medical oncology: The persistent gap between expectation and reality

CrossrefOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07666477: rTMS and Olfactory Training for Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07665762: Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07665268: Study Title: A Multicenter, Prospective, Modified Platform Trial Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Matched Standard of Care Controls in the Management of Nonhealing Pressure Ulcers.

Study type: INTERVENTIONAL. Phase: PHASE4.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07664644: Hybrid Type 1 Trial of a Parent-Based Intervention Addressing Social Media and Adolescent Alcohol Use

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07659197: Usefulness of the VExUS Protocol for Dry-Weight Adjustment in Hemodialysis Patients: The Multicenter VExHD Study

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07553715: Effectiveness of a Four-Session Focal Shock Wave Therapy Protocol in Women With Vulvodynia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07496697: Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07419490: Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07407920: Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07376486: Duodenal pulsENDO as an Early Treatment for Type 2 DM

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07206589: Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07193550: A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07009171: Study to Evaluate the Efficacy and Safety of KDS2010 in Overweight or Obese Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06952010: A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06892548: A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06673628: Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06661122: A Study to Learn About How Safe Darolutamide is and How Well it Works in Combination With Androgen Deprivation Therapy and Docetaxel in Routine Medical Care for Japanese Men With Low Volume Metastatic Hormone-Sensitive Prostate Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06595953: Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06238622: A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05831085: Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05519553: Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05280548: A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04570423: A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04323540: Treatment of Peri-implantitis With or Without Simultaneous Soft Tissue Augmentation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04067219: SkIn, Muscle and Bone Aging Determinants in HIV Infected-patients.

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02858323: Complement (C1q) Binding to HLA Antibodies in a Solid-phase Immunoassay and Clinical Effect on Platelet Transfusion

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01989572: Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01575548: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01352949: Stereophotogrammetry of the Torso in Healthy Individuals and Patients With Scoliosis, Chest Wall Deformations, or Obesity

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT00678821: Aerobic Exercise in Patients With Pulmonary Hypertension

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Nvidia bets on agentic AI to turbocharge biotech discovery

SiliconANGLEOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lilly, Astellas circle Sangamo assets as biotech files for bankruptcy

PharmaLiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China’s biotech boom: record 5,215 clinical drug trials reported in 2025

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Key Takeaways | Leveraging China’s biotech ecosystem

McDermott Will & SchulteOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fact check: Who did Eli Lilly give access to its obesity drug? White House says not Trump

IndyStarOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Diet pill death triggers raids

Bangkok PostOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Base-editing biotech launches straight onto NASDAQ in reverse merger with Boundless

FirstWord PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Reuters Health News Summary

DevdiscourseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Blues & The Not-So-Hidden Costs of Prior Art: Lessons in Pharma and Psychedelics

JD SupraOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A

ETF DatabaseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech's Silent Resurgence (5-Year Base Breakout)

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chlorthalidone Blood Pressure Drug Recalled Nationwide After FDA Warning

Evrim AğacıOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Pilot Targets Faster Early-Stage Drug Trial Starts | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Revolution Medicines (RVMD) Initiates Phase 3 Trial for Pancreatic Cancer Treatment

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Retail Investors Say Don’t Miss This Top Biotech Stock With Huge Upside Potential

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lilly’s Investigational Triple Agonist Retatrutide Reduces OSA Severity in Phase 3 Trial

Sleep ReviewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sen. Gillibrand Raises Concerns About China’s Ability To Attract U.S. Biotech Investment, Partners

Coalition For A Prosperous AmericaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haisco licenses two drug candidates to Nuvectis for $40m upfront

Investing.com UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Exclusive | Pro-life groups press Todd Blanche to settle FDA mail-in abortion pill case: ‘Unborn children are killed’

New York PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Haisco licenses two drug candidates to Nuvectis for $40m upfront By Investing.com

Investing.com AustraliaOriginal source